Wainberg earns Killam

Wednesday, April 4th, 2012

This week saw Dr. Mark A. Wainberg receive one of Canada’s most distinguished research awards, the Killam Prize in Health Sciences (awarded by the Canada Council for the Arts). Dr. Wainberg is the past Director of the Lady Davis Institute and is currently head of its HIV/AIDS research axis and Director of the McGill AIDS Centre; he is also a Professor of Medicine and of Microbiology and Immunology at McGill University. Among his many contributions to the field of HIV drug resistance, Wainberg helped identify 3TC as the first effective anti-viral drug. His current research focuses on novel concepts in preventing HIV infection in developing countries.

Interested in learning more about Dr. Wainberg’s work? Headway featured him a few issues back, as did the McGill News. And there’s always this video:

Comments are closed.